QC
INO icon

Quadrature Capital’s Inovio Pharmaceuticals INO Stock Holding History

Quadrature Capital’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
+258,928
New +$307K ﹤0.01% 1220
2026
Q1 		– Sell
-37,222
Closed -$64.8K – 1615
2025
Q4 		$64.8K Buy
37,222
+107
+0.3% +$236 ﹤0.01% 1148
2025
Q3 		$86.8K Buy
+37,115
New +$71.1K ﹤0.01% 895

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quadrature Capital's INO Position: Q2 2026 in Review

Quadrature Capital opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 258,928 shares worth $285K. The stake represents ﹤0.01% of the portfolio and ranks #1220 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in INO as recently as Q4 2025.

Quadrature Capital first reported a position in INO in Q3 2025 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Quadrature Capital held 258,928 shares of Inovio Pharmaceuticals worth $285K as of Q2 2026.
  • Inovio Pharmaceuticals was a new Quadrature Capital position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1220 holding.
  • Quadrature Capital first reported a position in Inovio Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.